BLTE
Belite Bio Inc
159.20$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +201.3% | +0.0% | +31.5% | +0.0% | +3.8% | +0.0% | -53.5% | +79.8% | -25.0% | +341.0% | +9.5% | -3.6% | +58.5% | -44.4% | +86.7% | +0.0% | -24.6% | +6.0% | +29.5% | +17.6% | -6.7% | +41.9% | +7.1% | +16.3% | – | |
| – | +0.0% | -27.6% | +0.0% | +34.2% | +0.0% | +5.4% | +0.0% | -71.3% | +429.7% | +46.2% | +10.3% | -22.5% | +17.0% | +63.7% | -5.6% | -33.4% | +0.0% | +108.0% | +45.0% | +45.6% | +7.0% | +94.1% | +5.8% | +26.5% | -1.9% | – | |
| – | +0.0% | +72.1% | +0.0% | +32.1% | +0.0% | +4.2% | +0.0% | -57.9% | +138.0% | +1.4% | +164.6% | +2.4% | -0.1% | +59.5% | -36.5% | +50.6% | +0.0% | -7.0% | +17.6% | +35.4% | +13.4% | +30.8% | +22.0% | +16.4% | +6.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | – | – | – | – | +3,300.0% | +576.5% | – | – | -75.6% | -34.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -50.0% | +0.0% | – | – | – | – | – | -776.5% | – | – | -81.7% | -50.0% | -66.7% | -200.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.